Page last updated: 2024-10-31

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Glioblastoma

n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide has been researched along with Glioblastoma in 1 studies

N-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide: calmodulin antagonist; structure given in first source
N-(4-aminobutyl)-5-chloronaphthalene-2-sulfonamide : A sulfonamide that is 5-chloronaphthalene-2-sulfonamide in which one of the hydrogens of the nitrogen atom is substituted by a 4-aminobutyl group.

Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiong, DD1
Xu, WQ1
He, RQ1
Dang, YW1
Chen, G1
Luo, DZ1

Other Studies

1 other study available for n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide and Glioblastoma

ArticleYear
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
    Oncology reports, 2019, Volume: 41, Issue:4

    Topics: Androstadienes; Antineoplastic Agents; Brain Neoplasms; Computational Biology; Drug Discovery; Gefit

2019